Print Page

Letters to Healthcare Providers
 
Safety alerts on Ketoconazole announced by US FDA, EU EMA and UK MHRA and on Metoclopramide announced by EU EMA (Letters to Healthcare Professionals)
 
 
 
Attachment:
  1. Safety alerts on Ketoconazole.pdf  
Related Information:
Singapore: Reminder on risk of extrapyramidal side effects with metoclopramide i... Posted 2025-09-12
台灣: 公告含metoclopramide成分藥品之風險再評估結果相關事宜 (Chinese only) Posted 2024-07-17
Singapore: Restrictions on the use of metoclopramide-containing products Posted 2016-09-22
Singapore: Amendments to the Dear Healthcare Professional Letter dated 23 July 2... Posted 2016-03-29
Singapore: Restrictions on the use of metoclopramide-containing products Posted 2015-07-24
China: Alert on metoclopramide-induced extrapyramidal reactions Posted 2015-04-25
Australia: Medicines Safety Update: Metoclopramide and neurological adverse even... Posted 2015-02-02
Canada: Association of metoclopramide with neurological adverse events (extrapyr... Posted 2015-01-06
Singapore: Update to the Primperan (metoclopramide) package insert for Singapore... Posted 2014-07-24
European Union: European Medicines Agency recommends changes to the use of metoc... Posted 2013-07-27
 
back